Thromboprophylaxis in Acutely Ill Medical Patients: Results of A Survey Among Italian Physicians

被引:3
|
作者
Dentali, Francesco [1 ]
Pomero, Fulvio [2 ]
La Regina, Micaela [3 ]
Orlandini, Francesco [3 ]
Turato, Sara [1 ]
Mazzone, Antonino [4 ]
Nozzoli, Carlo [5 ]
Fontanella, Andrea [6 ]
Ageno, Walter [1 ]
Agnelli, Giancarlo [7 ]
Campanini, Mauro [8 ]
机构
[1] Insubria Univ, Dept Clin Med, I-21100 Varese, Italy
[2] ASO S Croce E Carle, Dept Clin Med, Cuneo, Italy
[3] Presidio Ospedaliero Unico Levante Ligure, Dept Internal Med, La Spezia, Italy
[4] AO Osped Civile, Dept Internal Med, Legnano, Italy
[5] AO Careggi, Dept Internal Med, Florence, Italy
[6] Osped Buon Consiglio, Dept Internal Med, Naples, Italy
[7] Univ Perugia, Internal & Cardiovasc Med & Stroke Unit, I-06100 Perugia, Italy
[8] AOU Maggiore Carita, Dept Internal Med, Novara, Italy
关键词
venous thromboembolism; bleeding risk; thromboprophylaxis; RAMs; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; BLEEDING RISK; PREVENTION; ENOXAPARIN; COMPRESSION; MULTICENTER; VALIDATION;
D O I
10.1016/j.thromres.2014.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: acutely ill medical patients are at increased risk of venous thromboembolism (VTE) and often require thromboprophylaxis, but patient selection and adequate therapeutic decisions may be difficult due to the heterogeneity and the complexity of this population. We conducted a survey among a large cohort of Italian physicians to assess their approach to some important "grey" areas of VTE prevention in this setting. Methods: a questionnaire was distributed during the meeting of a national society of Internal Medicine (FADOI), held in May 2013. Four clinical scenarios describing areas of clinical uncertainty were administered to participants: the first on a patient with acute ischemic stroke; the second on a patient with severe renal insufficiency; the third on the duration of prophylaxis in the post-acute setting; and the last on a patient at high risk of VTE and at moderate risk of bleeding with preserved mobility. Results: 453 questionnaires were returned (participants mean age 48.5 years). About 70% of participants systematically assess VTE and bleeding risk in their clinical practice, but a minority of them use risk assessment models. Prolonged prophylaxis in the post-acute setting was voted by more than eighty percent of participants; replies to the other three clinical scenarios were more heterogeneous with none of the options selected by more than 60% of participant. Conclusion: physicians approach to "grey" areas of antithrombotic prophylaxis in the medical setting is quite heterogeneous and sometimes partially in contrast to recent guidelines, reinforcing the need for educational programs and high quality studies in this setting. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 50 条
  • [31] Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
    Chi, G.
    Goldhaber, S. Z.
    Kittelson, J. M.
    Turpie, A. G. G.
    Hernandez, A. F.
    Hull, R. D.
    Gold, A.
    Curnutte, J. T.
    Cohen, A. T.
    Harrington, R. A.
    Gibson, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1913 - 1922
  • [32] Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis
    Chi, G.
    Nafee, T.
    Korjian, S.
    Daaboul, Y.
    Harrington, R. A.
    Goldhaber, S. Z.
    Hull, R. D.
    Gold, A.
    Cohen, A. T.
    Gibson, C. M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1204 - 1205
  • [33] EnoxaparinA Review of its Use as Thromboprophylaxis in Acutely Ill, Nonsurgical Patients
    M. Asif A. Siddiqui
    Antona J. Wagstaff
    Drugs, 2005, 65 : 1025 - 1036
  • [34] Enoxaparin - A review of its use as thromboprophylaxis in acutely ill, nonsurgical patients
    Siddiqui, MAA
    Wagstaff, AJ
    DRUGS, 2005, 65 (07) : 1025 - 1036
  • [35] Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study
    Russell D. Hull
    Sebastian M. Schellong
    Victor F. Tapson
    Manuel Monreal
    Meyer-Michel Samama
    Alexander G. G. Turpie
    Peter Wildgoose
    Roger D. Yusen
    Journal of Thrombosis and Thrombolysis, 2006, 22 : 31 - 38
  • [36] Rivaroxaban and Extended Thromboprophylaxis in Acutely Ill Medical Patients with History of Cancer: Insights from the Magellan and Mariner Studies
    Spyropoulos, Alex C.
    Lipardi, Concetta
    Cohen, Alexander T.
    Vuckovic, Biljana
    Xu, Jianfeng
    Lu, Wentao
    Spiro, Theodore E.
    Barnathan, Elliot S.
    Raskob, Gary E.
    BLOOD, 2019, 134
  • [37] Mortality reduction with low molecular weight heparin thromboprophylaxis in acutely ill medical patients: The MEDENOX trial.
    Desjardins, L
    Cohen, AT
    Eldor, A
    Janbon, C
    Olsson, CG
    Samama, MM
    Turpie, AGG
    Weisslinger, N
    BLOOD, 1999, 94 (10) : 31A - 31A
  • [38] Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study
    Hull, Russell D.
    Schellong, Sebastian M.
    Tapson, Victor F.
    Monreal, Manuel
    Samama, Meyer-Michel
    Turpie, Alexander G. G.
    Wildgoose, Peter
    Yusen, Roger D.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 22 (01) : 31 - 38
  • [39] Thromboprophylaxis with enoxaparin in Germany -: Two surveys totalling 13165 acutely ill medical outpatients
    Kroeger, K.
    Paar, W. D.
    PHLEBOLOGIE, 2006, 35 (06) : 281 - 285
  • [40] Betrixaban in Acutely Ill Medical Patients Reply
    Cohen, Alexander T.
    Harrington, Robert A.
    Gibson, C. Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24):